Trademark: 90732749
Word
LUCIDA MEDICAL
Status
Pending
Status Code
653
Status Date
Friday, October 7, 2022
Serial Number
90732749
Mark Type
3000
Filing Date
Tuesday, May 25, 2021

Trademark Owner History

Classifications
9 Downloadable software for analysis of medical images and data; Downloadable software for providing medical diagnostic services; Downloadable software in the field of cancer for cancer screening, cancer detection and cancer diagnosis; Downloadable software for screening cancer; Downloadable software for detecting cancer; Downloadable software for diagnosing cancer; Downloadable software for screening, detecting and diagnosing prostate cancer; Downloadable software for the analysis of medical data; Downloadable data analysis software for screening, detecting and diagnosing cancer; Downloadable data analysis software for screening, detecting and diagnosing prostate cancer; Downloadable software for processing medical data; Downloadable data processing software for screening, detecting and diagnosing cancer; Downloadable data processing software for screening, detecting and diagnosing prostate cancer; Downloadable machine learning software for analysis of medical images and data; Downloadable machine learning software for screening, detecting and diagnosing cancer; Downloadable machine learning software for screening, detecting and diagnosing prostate cancer; Downloadable artificial intelligence software for analysis of medical images and data; Downloadable artificial intelligence software for screening, detecting and diagnosing cancer; Downloadable artificial intelligence software for screening, detecting and diagnosing prostate cancer; Downloadable software for MRI machines to detect cancer; Downloadable software for operating medical apparatus in the field of cancer; Downloadable software for medical imaging apparatus to detect cancer; Downloadable publications, namely, magazines, pamphlets, journals, in the field of medicine; Downloadable publications, namely, magazines, pamphlets, journals, in the field of cancer, cancer research, cancer screening, cancer diagnosis, cancer treatment, MRI, MRI machines and medical imaging
44 Provision of medical information in the field of prostate cancer; Provision of medical information in the field of cancer, cancer screening, cancer detection and cancer diagnosis; Medical services related to the treatment of cancer; Healthcare services related to the treatment of cancer; Medical analysis services related to the treatment of cancer; Medical analysis services for the diagnosis of cancer; Medical analysis services for the diagnosis of prostate cancer; Medical diagnostic testing, monitoring and reporting services; Medical diagnostic services for cancer; Medical diagnostic services for prostate cancer; Medical consulting services related to the treatment of cancer; Medical consulting services in the field of cancer, cancer screening, cancer detection and cancer diagnosis; Collation being analysis of information in the healthcare sector related to the treatment of cancer; Information and advisory services relating to the aforementioned
42 Software as a service (SaaS) featuring software for analysis of medical images and data; Platform as a service (PaaS) featuring software for analysis of medical images and data; Design and development of software; Software as a service (SaaS) featuring software in the field of cancer for cancer screening, cancer detection and cancer diagnosis; Software as a service (SaaS) featuring software for screening, detecting and diagnosing cancer; Software as a service (SaaS) featuring software for screening, detecting and diagnosing prostate cancer; Software as a service (SaaS) featuring software for the analysis of medical data; Software as a service (SaaS) in the nature of data analysis software for screening, detecting and diagnosing cancer; Software as a service (SaaS) in the nature of data analysis software for screening, detecting and diagnosing prostate cancer; Software as a service (SaaS) featuring software for processing medical data; Software as a service (SaaS) in the nature of data processing software for screening, detecting and diagnosing cancer; Software as a service (SaaS) in the nature of data processing software for screening, detecting and diagnosing prostate cancer; Software as a service (SaaS) in the nature of machine learning software for analysis of medical images and data; Software as a service (SaaS) in the nature of machine learning software for screening, detecting and diagnosing cancer; Software as a service (SaaS) in the nature of machine learning software for screening, detecting and diagnosing prostate cancer; Software as a service (SaaS) in the nature of artificial intelligence software for analysis of medical images and data; Software as a service (SaaS) in the nature of artificial intelligence software for screening, detecting and diagnosing cancer; Software as a service (SaaS) in the nature of artificial intelligence software for screening, detecting and diagnosing prostate cancer; Software as a service (SaaS) featuring software for MRI machines to detect cancer; Software as a service (SaaS) featuring software for medical imaging apparatus to detect cancer; Platform as a service (PaaS) featuring software in the field of cancer for cancer screening, cancer detection and cancer diagnosis; Platform as a service (PaaS) featuring software for screening, detecting and diagnosing cancer; Platform as a service (PaaS) featuring software for screening, detecting and diagnosing prostate cancer; Platform as a service (PaaS) featuring software for the analysis of medical data; Platform as a service (PaaS) in the nature of data analysis software platform for screening, detecting and diagnosing cancer; Platform as a service (PaaS) in the nature of data analysis software platform for screening, detecting and diagnosing prostate cancer; Platform as a service (PaaS) featuring software for the processing of medical data; Platform as a service (PaaS) in the nature of data processing software platform for screening, detecting and diagnosing cancer; Platform as a service (PaaS) in the nature of data processing software platform for screening, detecting and diagnosing prostate cancer; Platform as a service (PaaS) in the nature of machine learning platform for analysis of medical images and data; Platform as a service (PaaS) in the nature of machine learning software platform for screening, detecting and diagnosing cancer; Platform as a service (PaaS) in the nature of machine learning software platform for screening, detecting and diagnosing prostate cancer; Platform as a service (PaaS) in the nature of artificial intelligence software platform for analysis of medical images and data; Platform as a service (PaaS) in the nature of artificial intelligence software platform for screening, detecting and diagnosing cancer; Platform as a service (PaaS) in the nature of artificial intelligence software platform for screening, detecting and diagnosing prostate cancer; Platform as a service (PaaS) featuring software platforms for MRI machines to detect cancer; Platform as a service (PaaS) featuring software platforms for medical imaging apparatus to detect cancer; Design and development of software in the field of cancer, cancer screening, cancer detection and cancer diagnosis; Design and development of software for screening, detecting and diagnosing cancer; Design and development of software for screening, detecting and diagnosing prostate cancer; Design and development of data analysis software; Design and development of data analysis software for screening, detecting and diagnosing cancer; Design and development of data analysis software for screening, detecting and diagnosing prostate cancer; Design and development of data processing software; Design and development of data processing software for screening, detecting and diagnosing cancer; Design and development of data processing software for screening, detecting and diagnosing prostate cancer; Design and development of machine learning software; Design and development of machine learning software for screening, detecting and diagnosing cancer; Design and development of machine learning software for screening, detecting and diagnosing prostate cancer; Design and development of artificial intelligence software; Design and development of artificial intelligence software for screening, detecting and diagnosing cancer; Design and development of artificial intelligence software for screening, detecting and diagnosing prostate cancer; Design and development of software for MRI machines; Design and development of software for medical imaging apparatus; Scientific research services; Scientific research services in the field of cancer, cancer screening, cancer detection and cancer diagnosis; Scientific research services in the field of artificial intelligence and machine learning; Testing of computer software; Information and advisory services relating to the aforementioned
The mark consists of a blue four-pointed star with a white center surrounded by a plurality of gray circles of different sizes on the left side of the words "Lucida Medical" in black all on a white background.
The color(s) blue, grey, black, and white is/are claimed as a feature of the mark.
The wording "LUCIDA MEDICAL" has no meaning in a foreign language.
"MEDICAL"

Trademark Events
Apr 14, 2023
Suspension Checked ¿ To Attorney For Action
Feb 13, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Feb 13, 2023
Teas Change Of Correspondence Received
Feb 13, 2023
Teas Change Of Owner Address Received
Oct 7, 2022
Notification Of Letter Of Suspension E-Mailed
Oct 7, 2022
Letter Of Suspension E-Mailed
Oct 7, 2022
Suspension Letter Written
Sep 12, 2022
Teas/Email Correspondence Entered
Sep 12, 2022
Correspondence Received In Law Office
Sep 12, 2022
Assigned To Lie
Aug 8, 2022
Teas Response To Office Action Received
Feb 9, 2022
Notification Of Non-Final Action E-Mailed
Feb 9, 2022
Non-Final Action E-Mailed
Feb 9, 2022
Non-Final Action Written
Feb 7, 2022
Assigned To Examiner
Aug 20, 2021
Notice Of Design Search Code E-Mailed
Aug 19, 2021
New Application Office Supplied Data Entered
May 28, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24